Quantification of propiverine by liquid chromatography/electrospray tandem mass spectrometry: Application to a bioequivalence study of two formulations in healthy subjects

Journal of Pharmaceutical and Biomedical Analysis

Volumn 39, Issue 3-4, 2005, Pages 670-676

  Cho, Sung Hee ^a   Lee, Hun Woo ^a   Im, Ho Taek ^a   Park, Wan Su ^a   Baek, Minsun ^b   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Bioequivalence; LC MS MS; Multiple reaction monitoring; Propiverine

Indexed keywords

PROPIVERINE;

ACCURACY; ARTICLE; BIOEQUIVALENCE; CALIBRATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TABLET; TANDEM MASS SPECTROMETRY;

AREA UNDER CURVE; BENZILATES; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG INDUSTRY; HEPARIN; HUMANS; MANDELIC ACIDS; MASS SPECTROMETRY; MODELS, CHEMICAL; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TABLETS; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 23944454162     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.03.038     Document Type: Article

References (13)

1. W.D. Steers seventh ed. P.C. Walsh AB. Retik ED. Vaughan Jr. AJ. Wein Campbell's Urology vol. 1 1997 Saunders Philadelphia 870 915 (Chapter 26)
2. K. Miyamae, M. Yoshida, S. Murakami, H. Iwashita, M. Ohtani, K. Masunaga, and S. Ueda Pharmacology 69 2003 205 211
3. R.P.G. David Clin. Pharmacokinet. 42 2003 1243 1285
4. T. Marunaka, Y. Umeno, Y. Minami, E. Matsushima, M. Maniwa, K. Yoshida, and M. Nagamachi J. Chromatogr. 420 1987 43 52
5. K. Richter, S. Scheithauer, and D. Thümmler J. Chromatogr. B 708 1998 325 329
6. R. Oertel, K. Richter, J. Fauler, and W. Kirch J. Chromatogr. A 948 2002 187 192
7. K. Ikumi, Y. Ken-ichiro, M. Eiji, Y. Kazumasa, A. Tsutomu, and A. Shunji J. Chromatogr. B 799 2004 141 147
8. B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng Anal. Chem. 70 1998 882 889
9. I. Fu, E.J. Woolf, and B.K. Matuszewski J. Pharm. Biomed. Anal. 18 1998 347 357
10. Y.J. Lee, S.J. Jung, and C.K. Shim K-BE Test 2002 for Window, Version 1.2.1 2002
11. KFDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, Bioequivalence Division, Pharmacology Department, National Institute of Toxicology Department, 2003 (website: http://www.kfda.go.kr/ ).
12. H.H. Kim, and S.B. Han J. Pharm. Biomed. Anal. 31 2003 341 349
13. FDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, US Department of health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001 (website: http://www.fda.gov/cder/guidance/index.htm ).